Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures
ISRG posted strong Q1 growth, but rising rivals and tighter hospital budgets test its robotics dominance and pricing power.
Key Points in This Article: The robotics industry, projected to grow from $71.2 billion in 2023 to $200 billion by 2030, is driven by AI advancements and demand for automation in logistics and healthc
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $534.38, denoting a +2.44% move from the preceding trading day.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $515.09, marking a +1.12% move from the previous day.
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Over the past several years, one of the most impressive stocks in the healthcare sector has undeniably been Intuitive Surgical NASDAQ: ISRG. The company's robotics-assisted surgical devices have prove
Boston Scientific offers steady growth with broader exposure, while Intuitive Surgical leads in robotics but faces margin and tariff headwinds.
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $512.11, marking a -1.34% move from the previous day.
ISRG's robotic platforms, led by da Vinci and Ion, are transforming surgical precision and driving strong stock gains.
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $522.41, marking a -1.36% move from the previous day.
Intuitive Surgical trims margin outlook on tariff headwinds, but strong procedure growth and financial resilience bolster its long-term case.
Intuitive Surgical ISRG is currently in Phase 17 of its 18-Phase Adhishthana Cycle. While the recent correction may be causing concern among investors, from the perspective of Adhishthana Principles,
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE